This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
The technology assessment program at the Agency for Healthcare Research and Quality (AHRQ) provides technology assessments for the Centers for Medicare & Medicaid Services (CMS). These technology assessments are used by CMS to inform its national coverage decisions for the Medicare program as well as provide information to Medicare carriers.
CMS has asked AHRQ and the Tufts-New England Medical Center Evidence-based
Practice Center to perform a horizon scan of gene-based tests for cancer that are currently in
clinical use, or are being promoted or developed for clinical use.
Select to download the print version (PDF File, 680 KB). PDF Help.
Part I: Genetic Tests Currently Available for Clinical Use
Part II: Genetic Tests in Development for Clinical Use
A1. Glossary of acronyms used
A2. Synopsis of select commercial diagnostic laboratories
A3. Additional companies and Web sites
A4. Exploratory MEDLINE search strategy for Part II:
for 10 cancers
A5. Sample titles from searches of the gray literature
Database I: Genetic
tests currently available
Database II: One
page profiles of current genetic tests
Database III: Genetic
tests in development
Table A: Search strategy and results for Category I gray literature resources
Table B: Search strategy and results for Category II gray literature resources
Table C: Category III gray literature resources
Prepared for AHRQ under Contract No. 290-02-0022. By Kevin M. Chin, M.D., M.S., Benjamin Wessler, B.A., Priscilla Chew, M.P.H., and Joseph Lau, M.D.; Tufts-New England Medical Center Evidence-based Practice Center.
Current as of January 2006